Industry Experts with Jackie Hunter: Using Artificial Intelligence in Drug Discovery
Francesca Morgan
Industry Experts
10:51, 13th May 2019

Vox Media Player

With Accenture predicting that AI in healthcare could save the US healthcare economy $150 billion dollars, there is no wonder that this has engaged substantial technological growth within the sector in recent years. 

AI application within drug development and its focus on primary drug discovery remains firmly within its infancy, but how can we understand the real implications and value of AI in primary drug discovery? We turned to expert Dr Jackie Hunter, Board Director of bioscience division BenevolentAI, to discuss the fundamentals here behind her company, and the wider industry.

Also available on Itunes and Spotify.  

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Login or register to post comments

Recent Articles